OTHER CANCER
Clinical trials for OTHER CANCER explained in plain language.
Never miss a new study
Get alerted when new OTHER CANCER trials appear
Sign up with your email to follow new studies for OTHER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Matched conditions: OTHER CANCER
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for hidden genes in rare, inherited tumors
Knowledge-focused Recruiting nowThis study aims to find new genes linked to rare tumors called pheochromocytomas and paragangliomas, which often run in families. Researchers will analyze genetic and health information from 2,000 participants who have these tumors or related conditions. The goal is to better und…
Matched conditions: OTHER CANCER
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC